Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
X
XBI
State Street SPDR S&P Biotech ETF
136.2
0
USD
+9917.65%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+9917.65%
Monthly Change
+5.17%
6 month change
+11.88%
Year Change
+23.67%
Previous Close
1.3
6
Open
136.4
8
Low
136.1
5
High
136.7
3
Volume
649
Markets
US ETFs
XBI
Open full chart
Full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
NBIX
Neurocrine Biosciences Inc
88.32 M
622.68 K
1.13%
CRSP
CRISPR Therapeutics AG
88.24 M
1.68 M
1.12%
ACAD
ACADIA Pharmaceuticals Inc
88.22 M
3.30 M
1.12%
GRAL
GRAIL Inc
87.37 M
1.02 M
1.11%
SMMT
Summit Therapeutics Inc
83.85 M
4.79 M
1.07%
ARQT
Arcutis Biotherapeutics Inc
83.24 M
2.87 M
1.06%
BEAM
Beam Therapeutics Inc
81.67 M
2.95 M
1.04%
MLYS
Mineralys Therapeutics Inc
77.33 M
2.13 M
0.99%
NUVL
Nuvalent Inc
76.99 M
765.39 K
0.98%
DYN
Dyne Therapeutics Inc
76.19 M
3.90 M
0.97%
KYMR
Kymera Therapeutics Inc
76.02 M
977.05 K
0.97%
A
ACLX
Arcellx Inc
75.50 M
1.16 M
0.96%
S
SLNO
Soleno Therapeutics Inc
73.74 M
1.59 M
0.94%
CGON
CG oncology Inc
72.96 M
1.76 M
0.93%
IDYA
Ideaya Biosciences Inc
72.77 M
2.11 M
0.93%
VERA
Vera Therapeutics Inc
72.41 M
1.43 M
0.92%
APLS
Apellis Pharmaceuticals Inc
71.75 M
2.86 M
0.91%
SRPT
Sarepta Therapeutics Inc
69.62 M
3.24 M
0.89%
COGT
Cogent Biosciences Inc
65.74 M
1.85 M
0.84%
RXRX
Recursion Pharmaceuticals Inc
65.66 M
16.05 M
0.84%
1
2
3
4
5
6
7
8
News
First Quarter Earnings: Sharpening Sector Divergence
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Biotech Investors Are Tuning Out the MAHA Chaos
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)
FDA Commissioner Marty Makary Expected To Resign, Ending Turbulent Stint
Why I Now Favor A Barbell Model Over Ray Dalio’s All-Weather Portfolio (SPY)
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone
Broadcom, Google And Caterpillar Lead AI Charge On Must-See List